Stock Scorer

International Stem Cell CORP (ISCO)

International Stem Cell CORP reported revenue of 2.7M USD for the quarter ending 30 June 2026, up 9.3% from 2.4M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 2.7M +9.3%
Gross Profit Q2 '26 · ending 30 June 2026 1.5M -4.1%
Operating Income Q2 '26 · ending 30 June 2026 -35K -121.0%
Net Income Q2 '26 · ending 30 June 2026 -71K -155.0%
Cost of Revenue Q2 '26 · ending 30 June 2026 1.2M +31.3%
Operating Cash Flow Q2 '26 · ending 30 June 2026 167K —
Free Cash Flow Q2 '26 · ending 30 June 2026 160K —
Shares Outstanding Q2 '26 · ending 30 June 2026 8M +0.0%
EPS Q2 '26 · ending 30 June 2026 -0.08 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 9.1M-267K-418K-35K
20242024-12-31 9.1M-68K-209K-153K
20232023-12-31 7.8M-663K-131K849K
20222022-12-31 8.2M-183K-331K331K
20212021-12-31 7.2M-1.9M-899K-1.3M
20202020-12-31 7.1M-2.8M-2.7M-369K
20192019-12-31 9.5M-5.7M-4.3M-1.6M
20182018-12-31 11.1M-3.5M-2.1M-1.3M
20172017-12-31 7.5M-4.9M-6.1M-2.3M
20162016-12-31 7.2M-4.9M-1.1M-4.4M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-302.7M
Q1 '262026-03-312.3M
Q4 '252025-12-312.2M
Q3 '252025-09-302.4M
Q2 '252025-06-302.4M
Q1 '252025-03-312.1M
Q4 '242024-12-312.4M
Q3 '242024-09-302.2M
Q2 '242024-06-302.3M
Q1 '242024-03-312.1M
Q4 '232023-12-311.9M
Q3 '232023-09-302M
Q2 '232023-06-301.8M
Q1 '232023-03-312.1M
Q4 '222022-12-312.4M
Q3 '222022-09-301.7M
Q2 '222022-06-302M
Q1 '222022-03-312M
Q4 '212021-12-311.8M
Q3 '212021-09-301.8M

Gross Profit Quarterly

Revenue minus cost of sales. This filer tags no gross profit of its own..

PeriodEndingGross Profit
Q2 '262026-06-301.5M
Q1 '262026-03-311.4M
Q4 '252025-12-311.1M
Q3 '252025-09-301.3M
Q2 '252025-06-301.5M
Q1 '252025-03-311.1M
Q4 '242024-12-311.5M
Q3 '242024-09-301.2M
Q2 '242024-06-301.4M
Q1 '242024-03-311.2M
Q4 '232023-12-311M
Q3 '232023-09-301.2M
Q2 '232023-06-301.1M
Q1 '232023-03-311.3M
Q4 '222022-12-311.3M
Q3 '222022-09-301M
Q2 '222022-06-301.3M
Q1 '222022-03-311.3M
Q4 '212021-12-311.1M
Q3 '212021-09-301M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-35K
Q1 '262026-03-31-190K
Q4 '252025-12-31-313K
Q3 '252025-09-3094K
Q2 '252025-06-30167K
Q1 '252025-03-31-215K
Q4 '242024-12-3151K
Q3 '242024-09-30-90K
Q2 '242024-06-30149K
Q1 '242024-03-31-178K
Q4 '232023-12-31-424K
Q3 '232023-09-30-97K
Q2 '232023-06-30-144K
Q1 '232023-03-312K
Q4 '222022-12-3161K
Q3 '222022-09-30-300K
Q2 '222022-06-3031K
Q1 '222022-03-3125K
Q4 '212021-12-31-323K
Q3 '212021-09-30-623K

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-71K
Q1 '262026-03-31-220K
Q4 '252025-12-31-348K
Q3 '252025-09-3057K
Q2 '252025-06-30129K
Q1 '252025-03-31-256K
Q4 '242024-12-3111K
Q3 '242024-09-30-125K
Q2 '242024-06-30119K
Q1 '242024-03-31-214K
Q4 '232023-12-31-458K
Q3 '232023-09-30-131K
Q2 '232023-06-30492K
Q1 '232023-03-31-34K
Q4 '222022-12-3123K
Q3 '222022-09-30-343K
Q2 '222022-06-30-2K
Q1 '222022-03-31-9K
Q4 '212021-12-31-351K
Q3 '212021-09-30-165K

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-301.2M
Q1 '262026-03-31954K
Q4 '252025-12-311.1M
Q3 '252025-09-301M
Q2 '252025-06-30927K
Q1 '252025-03-31992K
Q4 '242024-12-31990K
Q3 '242024-09-30974K
Q2 '242024-06-30913K
Q1 '242024-03-31887K
Q4 '232023-12-31863K
Q3 '232023-09-30781K
Q2 '232023-06-30713K
Q1 '232023-03-31824K
Q4 '222022-12-311.1M
Q3 '222022-09-30690K
Q2 '222022-06-30718K
Q1 '222022-03-31725K
Q4 '212021-12-31735K
Q3 '212021-09-30814K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30167K
Q1 '262026-03-31121K
Q4 '252025-12-3132K
Q3 '252025-09-3049K
Q2 '252025-06-30-300K
Q1 '252025-03-31227K
Q4 '242024-12-31-74K
Q3 '242024-09-30257K
Q2 '242024-06-3023K
Q1 '242024-03-31-193K
Q4 '232023-12-31161K
Q3 '232023-09-3062K
Q2 '232023-06-30490K
Q1 '232023-03-31216K
Q4 '222022-12-3179K
Q3 '222022-09-3084K
Q2 '222022-06-30192K
Q1 '222022-03-31-23K
Q4 '212021-12-31-316K
Q3 '212021-09-30-224K

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30160K
Q1 '262026-03-3198K
Q4 '252025-12-3129K
Q3 '252025-09-3046K
Q2 '252025-06-30-332K
Q1 '252025-03-31222K
Q4 '242024-12-31-75K
Q3 '242024-09-30220K
Q2 '242024-06-30-97K
Q1 '242024-03-31-201K
Q4 '232023-12-31161K
Q3 '232023-09-3048K
Q2 '232023-06-30439K
Q1 '232023-03-31201K
Q4 '222022-12-3179K
Q3 '222022-09-3084K
Q4 '212021-12-31-326K
Q4 '202020-12-31-315K
Q3 '202020-09-30-279K
Q2 '202020-06-30-37K

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-308M
Q1 '262026-03-318M
Q3 '252025-09-308.2M
Q2 '252025-06-308M
Q1 '252025-03-318M
Q3 '242024-09-308M
Q2 '242024-06-308M
Q1 '242024-03-318M
Q3 '232023-09-308M
Q2 '232023-06-308M
Q1 '232023-03-318M
Q3 '222022-09-308M
Q2 '222022-06-308M
Q1 '222022-03-318M
Q3 '212021-09-308M
Q2 '212021-06-307.8M
Q3 '192019-09-307.5M
Q2 '192019-06-307.5M
Q1 '192019-03-317.4M
Q3 '182018-09-306.4M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.08
Q1 '262026-03-31-0.06
Q4 '252025-12-31-0.06
Q3 '252025-09-30-0.02
Q2 '252025-06-30-0.04
Q1 '252025-03-31-0.04
Q4 '242024-12-31-0.04
Q3 '242024-09-30-0.07
Q2 '242024-06-30-0.07
Q1 '242024-03-31-0.05
Q4 '232023-12-31-0.02
Q3 '232023-09-300.01
Q2 '232023-06-30-0.01
Q1 '232023-03-31-0.04
Q4 '222022-12-31-0.04
Q3 '222022-09-30-0.08
Q2 '222022-06-30-0.06
Q1 '222022-03-31-0.03
Q4 '212021-12-31-0.11
Q3 '212021-09-30-0.16